Jeremy Sternberg is a partner in the Boston office of the global law firm Holland & Knight LLP. Jeremy’s practice focuses on working with health care companies, including life sciences companies, on complex disputes, compliance matters, and government facing issues. Prior to joining Holland & Knight, Jeremy was a federal prosecutor in the Boston U.S. Attorney’s Office. Jeremy graduated from Tufts University with a B.A. in Economics and History and from the George Washington University Law School.
Cure Rare Disease, a non-profit organization (Tax ID number 82-2473513), is qualified as a tax-exempt organization under section 501(c)(3) of the IRS and has been designated as a “public charity” under section 170.